China's medical products administrator granted Jiangsu Hengrui Pharmaceuticals (SHA:600276) a drug registration certificate for its fluzoparib capsules for platinum-sensitive recurrent ovarian cancer ...
Source LinkChina's medical products administrator granted Jiangsu Hengrui Pharmaceuticals (SHA:600276) a drug registration certificate for its fluzoparib capsules for platinum-sensitive recurrent ovarian cancer ...
Source Link
Comments